What IKEDA MOHANDO does

IKEDA MOHANDO Co., Ltd. (株式会社池田模範堂) is a privately held Japanese over-the-counter (OTC) pharmaceutical manufacturer headquartered in Kamiichi, Toyama Prefecture, with regional offices in Tokyo, Nagoya, Osaka, and Fukuoka. The company specializes in dermatology and pediatric symptom relief, with its flagship 'MUHI' (ムヒ) brand of topical anti-itch and insect bite remedies dating to 1926 and approaching its 100-year anniversary in 2026. Its product portfolio spans topical creams, liquids, and patches for itching, eczema, chilblains, athlete's foot, scalp conditions, and wound care; oral itch tablets (Muhi AZ) and dermatology-specific launches such as Muhi ER (ear itching, April 2020) and Muhi Beta V Liquid (stubborn eczema/dermatitis, 2026); an Anpanman-branded pediatric line of cold syrups and wound care; Hibicare crack/chapping ointments; Asemuhi EX for sweat rash; Delicare for intimate-area itching; and the Ibikist anti-snoring product.

Underlying technical capability rests on proprietary topical OTC formulations and a dedicated MUHI Skin Research Center, supported by structured R&D output (publications, conference presentations, an internal Ikeda Mohando Award) and house IP covering formulation, dosage form (cream, liquid, patch, tablet, hydrocolloid pad), and indication targeting. The company also operates an extensive consumer-education library ('Skin Trouble Information' (肌トラブル情報館), baby/child skin care guides, insect bite information (虫さされ情報館), and itch-mechanism manga) that functions as a top-of-funnel content asset.

The business model is B2C mass-market OTC drug sales in Japan. Revenue is generated primarily through physical retail distribution via pharmacies and drugstores (with dedicated partner support pages and downloadable catalogs for retail staff), an official online store (shop.ikedamohando.co.jp), and other domestic online retailers. Commercial reach is augmented by TV advertising, celebrity endorsements (notably Number_i members), cross-IP collaborations (Pokemuhi), and event-based 100th-anniversary promotions. The customer base is segmented horizontally into general consumers with skin conditions and parents/caregivers of children seeking OTC pediatric symptom relief, with no disclosed enterprise, B2B, or institutional customer concentration.

Name

IKEDA MOHANDO

Legal name

株式会社池田模範堂

Website

https://ikedamohando.co.jp

Company type

Private

Founded year

1926

Operating status

Operating

Headcount range

251–500 employees

Short description

IKEDA MOHANDO is a privately held Japanese OTC pharmaceutical manufacturer that develops, produces, and sells dermatological, pediatric, and itch-relief products under the century-old MUHI brand to Japanese consumers via pharmacies, drugstores, and online retail.

Ownership category

akta.pro rank

Product category

OTC Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (32541)

SIC

Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• OTC pharmaceutical products
• Dermatological skin care
• Insect bite remedies
• Children's cold medicines
• Wound care products

Headquarters

HQ city

Kamiichi

HQ country

Japan

HQ region

Asia

Offices5 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. OTC Pharmaceutical Product Sales: Ikeda Mohando generates revenue through the manufacture and sale of over-the-counter pharmaceutical products for skin conditions, including insect bite treatments, anti-itch medications, cold medicines for children, and wound care products. Products are sold through retail pharmacies, drugstores, and the company's official online store.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

IKEDA MOHANDO manufactures and markets over-the-counter pharmaceutical products for skin conditions, including the long-selling MUHI brand of insect bite and anti-itch topical remedies, scalp and eczema treatments, children's cold and syrup medications, and wound care products. The company sells these products primarily through pharmacies, drugstores, and its own online shop in Japan.

Product overview

IKEDA MOHANDO is a Japanese pharmaceutical company that manufactures and sells OTC (over-the-counter) medications and skincare products. The company operates under the core Muhi (ムヒ) brand, which has been providing insect bite and itch remedies for over 100 years. Their product portfolio consists of multiple product lines: the Muhi insect bite/itch series (ムヒシリーズ), the Anpanman-themed children's series (ムヒのアンパンマンシリーズ), the Hibicare crack/heal series (ヒビケアシリーズ), Muhi ER for ear itching, Muhi Beta V liquid for eczema/dermatitis, Asemuhi EX for sweat rash, Muhi AZ tablets for oral itch relief, Muhi HD for scalp conditions, Delicare for intimate area care, Muhi Soft GX for severe itching, and cold remedies for children. The products range from topical ointments, liquids, patches, and tablets to hydrocolloid wound care products. The company also maintains research and development operations through the MUHI Skin Research Center.

Differentiator

Problem solved

Functional benefit

Products and services

• Muhi S (ムヒS) Long-selling topical itch and insect bite remedy cream for general consumers.
• Muhi ER (ムヒER) Anti-itch product specifically formulated for ear itching, particularly for hay fever sufferers, launched April 2020.
• Muhi Beta V Liquid (ムヒベタV液) Topical liquid for stubborn eczema, dermatitis, and persistent itching.
• Muhi AZ Tablets (ムヒAZ錠) Oral itch medication providing 12-hour lasting relief from itching.
• Muhi HD Series (ムヒHDシリーズ) Topical treatments for scalp itchiness and eczema, including standard and sting-free (HDm) formulations.
• Muhi Alpha EX (ムヒアルファEX) Topical treatment for severe, unbearable insect bites and itching, available in liquid and cream formulations.
• Muhi Patch A1 (ムヒパッチA1) Adhesive patch-style anti-itch treatment for insect bites that prevents scratching, available in 38 and 76 sheet packages.
• Muhi Soft GX Series (ムヒソフトGXシリーズ) Topical treatment for severe itching skin, available in cream and emulsion formulations.
• Muhi Baby (ムヒ・ベビーb / 液体ムヒベビー) Long-selling infant- and child-appropriate itch remedy cream and liquid formulations.
• Hibicare Ointment b (ヒビケア軟膏b) Medicinal ointment for treating painful finger and hand cracks and chapping.
• Hibicare FT (ヒビケアFT) Medicinal ointment specifically for heel cracks, utilizing pharmaceutical repair properties.
• Asemuhi EX Series (アセムヒEXシリーズ) Topical treatment for sweat-induced rash and itching, available in cream and liquid formulations.
• Muhi Children's Cold Syrup series (ムヒのこどもかぜシロップシリーズ) Anpanman-branded children's cold medications including cough syrup, cold syrup, rhinitis syrup, and cold granules.
• Muhi Wound Tape / Pad / Liquid (ムヒのキズテープ/パッド/きず液) Anpanman-branded wound care products including adhesive tapes, hydrocolloid pads, and sting-free antiseptic liquid.
• Odecure EX (オデキュアEX) Fast-acting treatment for painful boils and skin abscesses.
• Delicare series (デリケアシリーズ) Products for intimate area itching and irritation, including men's (Delicare Mz) and general formulations.
• Ibikist (イビキスト) Swedish-origin anti-snoring product used before bedtime as a new etiquette product.

Quantifiable outcome

• Muhi ER product launched April 2020 for ear itching conditions
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered minor.

• Ministry of Health, Labour and Welfare (厚生労働省)minorOthersListed as a related organization link on Ikeda Mohando's website, indicating institutional connection to government health regulatory body.
• Japan Pharmaceutical Society (日本薬学会)minorOthersListed as a related organization link indicating academic/professional society affiliation.
• Japan Dermatological Association (日本皮膚科学会)minorOthersListed as a related organization link indicating professional association connection in dermatology field.
• Japan Federation of Self-Medication Industries (日本一般用医薬品連合会)minorOthersListed as related organization. Focuses on proper handling of OTC medicine seals.
• Japan OTC Medicines Association (日本OTC医薬品協会)minorOthersListed as related organization providing drug education materials for elementary through high school students.
• Toyama Drug Discovery Consortium (くすりのシリコンバレーTOYAMA創造コンソーシアム)minorOthersListed as related organization representing regional pharmaceutical industry consortium in Toyama.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Kobayashi Pharmaceutical: Japanese consumer healthcare leader with products including skincare, dermatology remedies, and household health items. Comparable OTC business model, Japanese pharmacy/drugstore distribution, and brand-driven marketing approach.
• Rohto Pharmaceutical: Japanese OTC and consumer healthcare company with strong dermatology and eye-care franchises (Mentholatum, Rohto Eye). Direct competitor in OTC skin care with overlapping product formats (creams, ointments, patches) and Japanese retail distribution.
• Sato Pharmaceutical: Long-established Japanese OTC pharmaceutical company with brands like Stona and Yunker. Directly comparable in scale, channel footprint (pharmacies/drugstores), and focus on dermatology and household remedy categories.
• Earth Corporation: Japanese household and personal care manufacturer with itch-relief and insect repellent products. Competes with Ikeda Mohando's discontinued Musipale line and broader dermatology/insect bite categories in drugstores.
• Daiichi Sankyo Healthcare: OTC subsidiary of Daiichi Sankyo operating brands such as Loxonin S and Transino. Competes head-to-head with Ikeda Mohando in Japanese drugstores, with comparable dermatology and pain relief offerings distributed through identical retail channels.
• Taisho Pharmaceutical: One of Japan's largest OTC pharmaceutical companies, marketing brands like Lipovitan and a broad dermatology/consumer health portfolio. Direct competitor in Japanese OTC retail channels, overlapping with Ikeda Mohando's pharmacy distribution model and similar dermatology product positioning.
• Kowa Pharmaceutical: Mid-sized Japanese OTC pharmaceutical firm with brands across dermatology, pain relief, and consumer health. Similar mid-tier position, pharmacy/drugstore distribution, and dermatology product overlap with Ikeda Mohando's portfolio.

Broad incumbents

• Pola Orbis Holdings: Japanese skincare and cosmetics holding company with dermatology-adjacent consumer brands. Operates in adjacent skincare category through different retail channels (department stores, beauty specialty), making it a partial comparable for premium Japanese skin care positioning.
• Lion Corporation: Large Japanese consumer products company spanning oral care, household cleaners, and select OTC pharmaceuticals. Broader portfolio than Ikeda Mohando but competes in overlapping personal care categories through the same retail channels.

Emerging players

• Mandom Corporation: Japanese men's grooming and personal care company with selected dermatology positioning. Less direct overlap with Ikeda Mohando's core itch franchise but competes in adjacent male skin care categories through similar drugstore distribution.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/international-teachers-training-program

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IKEDA MOHANDO